Related content

Should alpha-interferon be included as standard treatment in multiple myeloma?

By Zulian G.B.  

European Journal of Cancer, Vol. 34, Iss. 1, 1998-01 ,pp. : 18-22

Elsevier

Access to resources Recommend Favorite

Should alpha-interferon be included as standard treatment in multiple myeloma?

By Browman G.P.  

European Journal of Cancer, Vol. 34, Iss. 1, 1998-01 ,pp. : 22-24

Elsevier

Access to resources Recommend Favorite

Should alpha-interferon be included as standard treatment in multiple myeloma?

By Ludwig H.   Fritz E.  

European Journal of Cancer, Vol. 34, Iss. 1, 1998-01 ,pp. : 12-17

Elsevier

Access to resources Recommend Favorite

Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple Myeloma

By  

Current Cancer Therapy Reviews, Vol. 10, Iss. 2, 2014-05 ,pp. : 70-79

Bentham Science Publishers

Access to resources Recommend Favorite

A Comparison of Polychemotherapy and Melphalan/Prednisone for Primary Remission Induction, and Interferon-alpha for Maintenance Treatment, in Multiple Myeloma. A Prospective Trial of the German Myeloma Treatment Group

By Peest D.   Deicher H.   Coldewey R.   Leo R.   Bartl R.   Bartels H.   Braun H.J.   Fett W.   Fischer J.T.   Gobel B.   Harms P.   Henke R.   Hoffmann L.   Kreuser E.D.   Maier W.D.   Meier C.R.   Oertel J.   Petit M.   Planker M.   Platzeck C.   Respondek M.   Schafer E.   Schumacher K.   Stennes M.   Stenzinger W.   Tirier C.   Wagner H.   Weh H.J.   von Wussow P.   Wysk J.  

European Journal of Cancer, Vol. 31, Iss. 2, 1995-01 ,pp. : 146-151

Elsevier

Access to resources Recommend Favorite